*Division of Clinical Pharmacology, Department of Medical Sciences, Uppsala University Hospital, Uppsala University, Uppsala, Sweden †InsightRX, San Francisco, California R. Keizer is co-owner of InsightRX, a precision dosing company. A.-K. Hamberg declares no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Hamberg et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: